Bonraybio Co., Ltd. (TPE:6955)
Taiwan
· Delayed Price · Currency is TWD 165.50
-6.50 (-3.78%)
At close: Mar 9, 2026
Bonraybio Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 96.28 | 68.37 | 25.73 | 1.69 | -31.71 | -41.16 |
| Depreciation & Amortization | 11.73 | 11.15 | 10.64 | 9.37 | 11.15 | 12.3 |
| Other Amortization | 1.04 | 0.68 | - | 0.14 | 0.1 | 0.12 |
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.42 | - |
| Stock-Based Compensation | 0.03 | 0.03 | - | 0.08 | 0.52 | 0.79 |
| Other Operating Activities | -0.13 | -2.95 | -0.47 | -0.68 | -3.43 | 0.6 |
| Change in Accounts Receivable | -4.05 | -5.14 | -9.36 | -0.1 | -3.85 | 2.26 |
| Change in Inventory | -20.92 | -8.33 | -2.59 | -2.88 | -0.89 | -3.25 |
| Change in Accounts Payable | 1.78 | 1.49 | -0.1 | 0.2 | 2.13 | -0.81 |
| Change in Unearned Revenue | -0.07 | 4.13 | -0.52 | 1.58 | -0.14 | 0.42 |
| Change in Other Net Operating Assets | 6.29 | 10.72 | 3.57 | 2.59 | 0.61 | 5.85 |
| Operating Cash Flow | 91.99 | 80.14 | 26.9 | 11.98 | -25.09 | -22.88 |
| Operating Cash Flow Growth | 34.84% | 197.95% | 124.50% | - | - | - |
| Capital Expenditures | -14.04 | -2.17 | -5.63 | -4.08 | -2.96 | -2.04 |
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - |
| Sale (Purchase) of Intangibles | -15.8 | -8.85 | -4.12 | -3.87 | -1.68 | -3.87 |
| Investment in Securities | -254.4 | - | 9.8 | 4.14 | -73.44 | -58.11 |
| Other Investing Activities | -0.02 | -0.42 | 3.65 | -0.23 | 1.38 | 0.31 |
| Investing Cash Flow | -284.26 | -11.45 | 3.7 | -4.04 | -76.69 | -63.71 |
| Long-Term Debt Repaid | - | -3.07 | -3.03 | -2.87 | -2.73 | -2.71 |
| Net Debt Issued (Repaid) | -3.21 | -3.07 | -3.03 | -2.87 | -2.73 | -2.71 |
| Issuance of Common Stock | 227.69 | 227.69 | - | 13.78 | 164.58 | 0.2 |
| Common Dividends Paid | -32.35 | -3.42 | - | - | - | - |
| Financing Cash Flow | 192.13 | 221.2 | -3.03 | 10.91 | 161.85 | -2.52 |
| Foreign Exchange Rate Adjustments | 1.48 | 3.41 | -0.11 | 0.55 | -0.77 | -0.7 |
| Net Cash Flow | 1.33 | 293.3 | 27.46 | 19.4 | 59.29 | -89.8 |
| Free Cash Flow | 77.95 | 77.96 | 21.26 | 7.9 | -28.05 | -24.92 |
| Free Cash Flow Growth | 20.85% | 266.69% | 169.26% | - | - | - |
| Free Cash Flow Margin | 27.15% | 34.98% | 13.32% | 7.43% | -49.83% | -93.71% |
| Free Cash Flow Per Share | 3.18 | 3.42 | 0.94 | 0.39 | -1.76 | -1.83 |
| Cash Interest Paid | 0.14 | 0.18 | 0.22 | 0.15 | 0.21 | 0.23 |
| Cash Income Tax Paid | 0.03 | 0.03 | 0.03 | - | - | - |
| Levered Free Cash Flow | 28.03 | 42.3 | 4.93 | 0.88 | -23.28 | - |
| Unlevered Free Cash Flow | 28.14 | 42.41 | 5.07 | 0.97 | -23.15 | - |
| Change in Working Capital | -16.97 | 2.86 | -9 | 1.38 | -2.14 | 4.47 |
Source: S&P Capital IQ. Standard template. Financial Sources.